Materiały źródłowe

• #1 Vestibular schwannoma (acoustic neuroma) – UpToDate

  https://www.uptodate.com/contents/vestibular-schwannoma-acoustic-neuroma

  Vestibular schwannomas commonly cause morbidity related to hearing loss, dizziness, and vestibular dysfunction, and large tumors pose risk of facial nerve dysfunction as well as symptoms due to mass effect on the adjacent brainstem. […] Both surgery and radiation therapy are used to treat schwannomas, and treatment decisions are optimally made with multidisciplinary input from neurosurgery, otolaryngology, and radiation oncology. […] Radiation therapy […] Local control and hearing preservation […] Surgery […] Surgical techniques […] Outcomes […] Surgical risks and complications.

• #2 Acoustic Neuroma Treatment | Vestibular Schwannoma | Duke Health

  https://www.dukehealth.org/treatments/ear-nose-and-throat/acoustic-neuroma

  Duke experts regularly treat rare, noncancerous growths called acoustic neuromas (also called vestibular schwannomas) found on the nerves responsible for balance and hearing. Preserving your hearing and balance, avoiding or minimizing facial paralysis, and reducing your pain are equally important goals. We continually evaluate how to maximize your quality of life during and after acoustic neuroma treatment. […] Acoustic neuroma treatment involves a team of specialists, including neurosurgeons, otolaryngologists, otologists and neurotologists (specialized ear, nose, and throat doctors who complete an additional two years of training to treat ear disorders), and radiation oncologists, among others. This team works closely with you to create an individualized treatment plan that addresses your unique situation and needs.

• #3 Schwannoma: What It Is, Causes, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17877-schwannoma

  Treatment for schwannoma depends on where the tumor is in your body and how quickly it’s growing. […] Some treatment options include: […] Observation/watch and wait: If the tumor is benign, growing very slowly and you’re experiencing no or very mild symptoms, your healthcare provider may recommend closely monitoring it instead of treating it. […] Surgery: If the tumor is growing more quickly or causing other problems, your healthcare provider may recommend removing it with surgery. […] Radiation therapy: Stereotactic radiosurgery (SRS) uses many precisely focused radiation beams to destroy tumors. […] Malignant (cancerous) schwannomas may be treated with immunotherapy and chemotherapy medications as well.

• #4 Schwannoma – Overview – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/schwannoma/cdc-20352974

  Surgeons carefully remove schwannomas while taking care to preserve nerve fascicles that aren’t affected by the tumors. […] Schwannoma treatment depends on where the abnormal growth is located and whether it is causing pain or growing quickly. Treatment options include: […] Surgery. An experienced peripheral nerve surgeon can remove the tumor if it is causing pain or growing quickly. Schwannoma surgery is done under general anesthesia. […] Radiation therapy. Radiation therapy is used to help control the tumor growth and improve your symptoms. It may be used in combination with surgery. […] Stereotactic radiosurgery. If the tumor is near vital nerves or blood vessels, a technique called stereotactic body radiation therapy may be used to limit damage to healthy tissue.

• #5 Expert guidance for vestibular schwannomas’ complex treatment decisions – Mayo Clinic

  https://www.mayoclinic.org/medical-professionals/neurology-neurosurgery/news/expert-guidance-for-vestibular-schwannomas-complex-treatment-decisions/mac-20534886

  Expert guidance for vestibular schwannomas’ complex treatment decisions […] „We’re now prioritizing functional outcomes over a definitive cure,” says Michael J. Link, M.D., a neurosurgeon at Mayo Clinic in Rochester, Minnesota. „There are multiple reasonable treatment options, and patient preference plays a major role in shared decision-making.” […] „Depending on the individual patient and tumor, the strategies include a wait-and-scan approach, irradiation, microsurgery, or a combination of these methods,” Dr. Link says. „Each strategy has advantages and limitations. Data show that quality of life is affected more by the diagnosis itself and patient-related factors than by the actual treatment choice.” […] „Lifelong follow-up is recommended due to the tumor’s capacity for saltatory or delayed growth,” Dr. Link says. „Worsening symptoms aren’t reliable barometers for tumor growth.”

• #6 Schwannoma: What It Is, Causes, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17877-schwannoma

  Treatment for schwannoma depends on where the tumor is in your body and how quickly it’s growing. […] Some treatment options include: […] Observation/watch and wait: If the tumor is benign, growing very slowly and you’re experiencing no or very mild symptoms, your healthcare provider may recommend closely monitoring it instead of treating it. […] Surgery: If the tumor is growing more quickly or causing other problems, your healthcare provider may recommend removing it with surgery. […] Radiation therapy: Stereotactic radiosurgery (SRS) uses many precisely focused radiation beams to destroy tumors. […] Malignant (cancerous) schwannomas may be treated with immunotherapy and chemotherapy medications as well.

• #7 Schwannoma | Other conditions | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/other-conditions/schwannoma

  Treatment depends on where the tumour is in your body and your symptoms. Your specialist may monitor you carefully at first rather than suggest treatment. They will see you regularly and check any symptoms you have. They will examine you at each appointment and you may have some tests. […] The main treatment for schwannoma is surgery to remove the tumour. The type of surgery you have depends on where in the body the tumour is. […] You may have stereotactic radiotherapy or radiosurgery. Both treatments target high doses of radiotherapy to the tumour. […] You will also have treatment to control any pain you have. You might see a doctor who specialises in pain control. […] The treatment you have may include: regular check-up appointments with tests – these may include, MRI scans hearing tests and eye tests, surgery, targeted radiotherapy, pain control. […] Controlling the pain is very important in this condition. Removing the schwannoma by surgery can also help relieve the pain.

• #8 Schwannoma – Symptoms, Causes, TreatmentsSecond Opinion IconGroup 9Group 49

  https://www.barrowneuro.org/condition/schwannoma/

  In situations where complete removal of the tumor is not feasible or if a person is not a suitable candidate for surgery, other treatments can be considered. […] They include: Observation: If your schwannoma is small, slow-growing, and not causing significant symptoms, your doctor may recommend regular monitoring through imaging tests to observe any changes over time. […] Radiation therapy: In some cases, radiation therapy may be used to shrink the tumor or prevent growth. […] Stereotactic radiosurgery: With this technique, doctors precisely deliver radiation without making an incision. […] Medications: Certain medications, like pain relievers or corticosteroids, may be prescribed to manage pain or inflammation associated with the tumor.

• #9 Contemporary Management of Vestibular Schwannoma | AAO-HNS Bulletin

  https://bulletin.entnet.org/clinical-patient-care/article/22834080/contemporary-management-of-vestibular-schwannoma

  Once identified, a thorough discussion of treatment options is warranted. Patients may be offered a wait and scan approach, stereotactic radiotherapy, or open microsurgery. In general, the factors that will affect the initial treatment recommendation are tumor size, hearing status, and patient age, in addition to patient preference. […] The management of VS has dramatically changed as the understanding of the natural history of these tumors has become better. […] This watchful waiting may be a good choice for patients with small tumors and excellent hearing in the ipsilateral ear; patients over age 65 or medically frail patients may also benefit from this approach. […] Preservation of hearing function is another commonly expressed reason for opting for serial imaging. […] Although there is technically no upper size limit for observation with serial imaging, significant posterior fossa symptoms including brain stem impaction and certainly compression would push most patients toward intervention.

• #10

  https://link.springer.com/article/10.1007/s10143-011-0307-8

  Vestibular schwannomas are benign intracranial tumors arising from the vestibular nerve. Treatment options include observation, stereotactic radiosurgery, fractionated radiotherapy, and microsurgery. […] Without intervention, 2954% of tumors will grow and 1626% of patients require additional treatment, with 5463% preserving functional hearing. With radiosurgery, only 24% require additional treatment and hearing preservation is accomplished in 4466% of cases. […] With fractionated radiotherapy, 37% will require additional treatment and hearing preservation is reported at 5994% of patients, although long-term outcomes are not known. Microsurgery is an alternative for eligible patients, with fewer than 2% requiring additional treatment; however, the risk of hearing loss, facial neuropathy, and other morbidities is relatively high. […] Additional prospective comparative trials and randomized studies are needed to improve our understanding of the relative benefits of each modality.

• #11 Expert guidance for vestibular schwannomas’ complex treatment decisions – Mayo Clinic

  https://www.mayoclinic.org/medical-professionals/neurology-neurosurgery/news/expert-guidance-for-vestibular-schwannomas-complex-treatment-decisions/mac-20534886

  Expert guidance for vestibular schwannomas’ complex treatment decisions […] „We’re now prioritizing functional outcomes over a definitive cure,” says Michael J. Link, M.D., a neurosurgeon at Mayo Clinic in Rochester, Minnesota. „There are multiple reasonable treatment options, and patient preference plays a major role in shared decision-making.” […] „Depending on the individual patient and tumor, the strategies include a wait-and-scan approach, irradiation, microsurgery, or a combination of these methods,” Dr. Link says. „Each strategy has advantages and limitations. Data show that quality of life is affected more by the diagnosis itself and patient-related factors than by the actual treatment choice.” […] „Lifelong follow-up is recommended due to the tumor’s capacity for saltatory or delayed growth,” Dr. Link says. „Worsening symptoms aren’t reliable barometers for tumor growth.”

• #12 Neurilemmoma (Schwannoma) Treatment & Management: Medical Therapy, Surgical Therapy, Complications

  https://emedicine.medscape.com/article/1256405-treatment

  Neurilemmomas (neurilemomas; also referred to as schwannomas) can cause a functional deficit because of local pressure on the nerve of origin. […] In a study assessing trends in management of unilateral vestibular schwannoma at Johns Hopkins University from 1997 through 2007, Tan et al noted an increase in cases observed with follow-up scanning (from 10.5% to 28.0%) and recommended for radiation (from 0% to 4.0%), along with a decrease in surgical cases (from 89.5% to 68.0%). […] Like most benign tumors, neurilemmomas respond well to local resection. […] Effective use of stereotactic radiosurgery (SRS) for these types of lesions has been reported. […] Endoscopic approaches have been used for schwannomas of the head and neck. […] The most common complication of surgical treatment of neurilemmoma is initial neurapraxia; however, this neurologic deficit can be permanent, depending on the resection of neural tissue.

• #13 Spinal Schwannoma Diagnosis & Treatment – NYC | Columbia Neurosurgery in New York City

  https://www.neurosurgery.columbia.edu/patient-care/conditions/spinal-schwannoma

  Schwannomas are nerve sheath tumors, or tumors that originate from the layer of insulation that surrounds nerve fibers. At the Spine Hospital at the Neurological Institute of New York, we specialize in treating spinal schwannomas. […] The treatment of spinal schwannomas depends on the size, location, and symptoms of the tumor. Small tumors producing no pressure on nearby tissues in patients with no symptoms can often be observed over time with intermittent MR scans. […] For larger or symptomatic tumors, or tumors showing growth over time, microsurgical removal is usually recommended. In most patients, complete removal of these tumors can be safely achieved using a surgical microscope, very fine instruments, and an array of microsurgical techniques. In many cases, patients experience an improvement in neurological function. […] In some patients with large dumbbell tumors, spinal stabilization and fusion may be performed following complete tumor removal.

• #14 Surgery for Acoustic Neuroma (Vestibular Schwannoma) | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/cancer-care/types/acoustic-neuroma/treatment/surgery-acoustic-neuroma

  Surgeons Samuel Selesnick (left) and Cameron Brennan are devoted to providing compassionate care for people with acoustic neuromas (vestibular schwannomas). […] Depending on your acoustic neuroma (vestibular schwannoma) symptoms, size and location, and other important factors, Memorial Sloan Kettering experts may recommend surgery. […] The aim of surgery is to remove as much of the tumor as possible while preserving important nerves, especially the nerve controlling movement in the face. In some cases, if we are concerned that surgery may damage these nerves, we may not be able to remove the entire tumor. […] Improvements in imaging technologies and skull-base surgical techniques have made surgery for acoustic neuromas safer and more effective than ever before. […] Surgical approaches for removal of an acoustic tumor include:

• #15 Vestibular Schwannoma Surgery | Treatment Options

  https://www.valleygammaknife.com/vestibular-schwannoma-surgery/

  Acoustic neuroma surgery involves the collaboration of different surgical experts. Usually, neurosurgeons and ENT surgeons work together to perform surgeries to remove acoustic neuromas. […] There are several approaches to vestibular schwannoma surgery: Retrosigmoid approach, Translabyrinthine approach, Middle fossa approach. […] All of these techniques can be successful at removing acoustic neuromas, but each one is best for specific cases. So, your vestibular schwannoma surgery specialist is going to decide which approach to take based on your individual case. […] Surgery is always risky. No matter how many medical advancements we make, it’s likely that surgical risks will always be around. […] With that, we need to go over the potential risks that surgical patients may have as a result of vestibular schwannoma surgery. Here is a list of the most common complications that this kind of procedure can present: Cerebrospinal fluid leak, Meningitis, Facial nerve paralysis, Headache, Disordered vestibular compensation, Cerebellar injury, Brain stem injury, Vascular complications in the affected ear.

• #16

  https://www.aurorahealthcare.org/services/aurora-spine-services/schwannoma

  Schwannomas are often surgically removed, especially if theyre causing symptoms. During the procedure, your surgeon will carefully open the nerve and access the tumor. The nerve will be monitored using advanced intraoperative electrophysiological during surgery. […] If your schwannoma is large, you may need radiation and chemotherapy. One option is stereotactic spine radiosurgery, such as CyberKnife, which uses highly focused beams of radiation to destroy the tumor. This type of procedure doesnt require an incision, which means less damage to normal tissue and no recovery time.

• #17 Get Schwannoma Treatment | Cleveland Clinic

  https://my.clevelandclinic.org/services/schwannoma-treatment

  Cleveland Clinic has pioneered a minimally invasive schwannoma treatment that lets us remove your tumor through your nose instead of through an opening in your skull. It can mean faster recovery, less time in the hospital and a lower risk of complications after surgery. […] Your personalized schwannoma treatment plan depends on your test results, age, health, where the tumor is, how big it is and if its cancerous or benign. Based on these things, your provider might recommend: […] We often recommend surgery to stop the tumor from growing and prevent symptoms that can happen when the tumor presses on surrounding nerves. Cleveland Clinic has pioneered an innovative, minimally invasive procedure where we can remove the entire tumor through your nose or near your ear without disturbing your nearby nerves, tissues and blood vessels.

• #18 Get Schwannoma Treatment | Cleveland Clinic

  https://my.clevelandclinic.org/services/schwannoma-treatment

  Cleveland Clinic has pioneered a minimally invasive schwannoma treatment that lets us remove your tumor through your nose instead of through an opening in your skull. It can mean faster recovery, less time in the hospital and a lower risk of complications after surgery. […] Your personalized schwannoma treatment plan depends on your test results, age, health, where the tumor is, how big it is and if its cancerous or benign. Based on these things, your provider might recommend: […] We often recommend surgery to stop the tumor from growing and prevent symptoms that can happen when the tumor presses on surrounding nerves. Cleveland Clinic has pioneered an innovative, minimally invasive procedure where we can remove the entire tumor through your nose or near your ear without disturbing your nearby nerves, tissues and blood vessels.

• #19 Schwannomas & Vestibular Schwannomas | the holistic neurosurgeon

  https://www.theholisticneurosurgeon.com/schwannomas-vestibular-schwannomas

  If you do have facial weakness it can affect your ability to close your eye, necessitating eye drops and sometimes patches to protect the eye in the short term. […] Most vestibular schwannomas are diagnosed after the patient experiences a loss of hearing, which can be partial or total. Following surgery, the majority of patients will lose their hearing completely in the affected ear. […] Some patients experience tinnitus (hearing a noise such as a high pitch noise or ringing sound) in the affected ear. […] Patients often experience dizziness/balance problems immediately following surgery. This usually improves over days to weeks. Persisting balance problems can be helped with dedicated balance physiotherapy. […] There is a risk of infection which can be of the skin/wound, or less commonly brain fluid (meningitis). The majority of infections can be treated satisfactorily with antibiotics, sometimes surgery to wash the infected area is required (approximately 2% risk).

• #20 Vestibular Schwannoma Surgery | Treatment Options

  https://www.valleygammaknife.com/vestibular-schwannoma-surgery/

  Acoustic neuroma surgery involves the collaboration of different surgical experts. Usually, neurosurgeons and ENT surgeons work together to perform surgeries to remove acoustic neuromas. […] There are several approaches to vestibular schwannoma surgery: Retrosigmoid approach, Translabyrinthine approach, Middle fossa approach. […] All of these techniques can be successful at removing acoustic neuromas, but each one is best for specific cases. So, your vestibular schwannoma surgery specialist is going to decide which approach to take based on your individual case. […] Surgery is always risky. No matter how many medical advancements we make, it’s likely that surgical risks will always be around. […] With that, we need to go over the potential risks that surgical patients may have as a result of vestibular schwannoma surgery. Here is a list of the most common complications that this kind of procedure can present: Cerebrospinal fluid leak, Meningitis, Facial nerve paralysis, Headache, Disordered vestibular compensation, Cerebellar injury, Brain stem injury, Vascular complications in the affected ear.

• #21 Acoustic Neuromas (Vestibular Schwannoma) – Neurosurgery

  https://med.virginia.edu/neurosurgery/services/gamma-knife/disorders-treated/acoustic-neuromas-vestibular-schwannoma/

  Surgical resection […] Stereotactic radiosurgery […] Monitoring without treatment. […] The exact type of operation done depends on the size of the tumor and the level of hearing in the affected ear. If the tumor is very small, hearing may be saved. As the tumor grows larger, surgical removal is more complicated because the tumor may have thinned-out the nerves that control facial movement, hearing, and balance and may also have affected other nerves and structures of the brain. Surgery offers immediacy but with higher up-front risk. The risks of surgery include cerebrospinal fluid leak (5% to 17% risk), meningitis, hydrocephalus, and a wound infection. Other common effects include a period of headaches or balance difficulties. Other potential risks of surgery include facial weakness. This risks increase with size of the tumor and the type of surgical procedure utilized.

• #22 Expert guidance for vestibular schwannomas’ complex treatment decisions – Mayo Clinic

  https://www.mayoclinic.org/medical-professionals/neurology-neurosurgery/news/expert-guidance-for-vestibular-schwannomas-complex-treatment-decisions/mac-20534886

  „The goal is maximal tumor removal with preservation of neurological function,” Dr. Link says. […] To minimize those complications, a tumor remnant might be left around the facial nerve and brainstem. About 30% of tumors regrow to some degree after subtotal tumor resection. As described in a study published in the August 2021 issue of Acta Neurochirurgica, Mayo Clinic usually treats residual tumors with adjuvant radiosurgery.

• #23

  https://link.springer.com/article/10.1007/s10143-011-0307-8

  Vestibular schwannomas are benign intracranial tumors arising from the vestibular nerve. Treatment options include observation, stereotactic radiosurgery, fractionated radiotherapy, and microsurgery. […] Without intervention, 2954% of tumors will grow and 1626% of patients require additional treatment, with 5463% preserving functional hearing. With radiosurgery, only 24% require additional treatment and hearing preservation is accomplished in 4466% of cases. […] With fractionated radiotherapy, 37% will require additional treatment and hearing preservation is reported at 5994% of patients, although long-term outcomes are not known. Microsurgery is an alternative for eligible patients, with fewer than 2% requiring additional treatment; however, the risk of hearing loss, facial neuropathy, and other morbidities is relatively high. […] Additional prospective comparative trials and randomized studies are needed to improve our understanding of the relative benefits of each modality.

• #24 Schwannoma | Expert Surgeon | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/schwannoma

  Schwannoma is a type of benign tumor that originates from Schwann cellsessential components of the peripheral nervous system. […] Understanding schwannomas, their symptoms, diagnosis, and available treatment options is vital for individuals facing this diagnosis. […] The main treatment options for a schwannoma are surgery and, in some cases, radiation therapy. Alternatively, a „watch-and-wait” approach can be taken to observe the schwannoma that is small and asymptomatic. […] Surgery is the primary treatment method, and the only potentially curative option, for symptomatic schwannomas. With total surgical removal, recurrence is extremely rare. Most patients report improvement in their symptoms after surgery. […] In some cases, radiation therapy may be performed after surgery for a residual tumor, or as primary treatment when surgery is not an option. This involves the delivery of high-energy radiation beams to the tumor site to prevent its growth and potentially shrink the tumor.

• #25

  https://link.springer.com/article/10.1007/s10143-011-0307-8

  Vestibular schwannomas are benign intracranial tumors arising from the vestibular nerve. Treatment options include observation, stereotactic radiosurgery, fractionated radiotherapy, and microsurgery. […] Without intervention, 2954% of tumors will grow and 1626% of patients require additional treatment, with 5463% preserving functional hearing. With radiosurgery, only 24% require additional treatment and hearing preservation is accomplished in 4466% of cases. […] With fractionated radiotherapy, 37% will require additional treatment and hearing preservation is reported at 5994% of patients, although long-term outcomes are not known. Microsurgery is an alternative for eligible patients, with fewer than 2% requiring additional treatment; however, the risk of hearing loss, facial neuropathy, and other morbidities is relatively high. […] Additional prospective comparative trials and randomized studies are needed to improve our understanding of the relative benefits of each modality.

• #26 Schwannomas & Vestibular Schwannomas | the holistic neurosurgeon

  https://www.theholisticneurosurgeon.com/schwannomas-vestibular-schwannomas

  Hydrocephalus is a build up of the CSF on the brain which can occur before or after surgery as a consequence of the tumour or its treatment. If this occurs you may require a temporary or permanent drain (shunt) placed into the brain. […] Recovery from this operation is slow and steady. It will take approximately six to twelve weeks. Some people may take longer. […] If you drive you can continue to do so after your operation and you do not need to notify the DVLA with this type of tumour. […] Return to work will depend on what sort of work you do and when you feel able. […] Follow-up scans will be arranged for a minimum of 10 years following surgery to check for any re-growth. […] Radio-surgery is usually offered to patients with small but growing tumours, as an alternative or adjunct to surgery. This can be delivered in one dose (single fraction) or several doses (fractionated radiotherapy) which can be a course delivered over a period of up to six weeks on a daily basis).

• #27 Vestibular Schwannoma Surgery | Treatment Options

  https://www.valleygammaknife.com/vestibular-schwannoma-surgery/

  After you have your vestibular schwannoma surgery, you’ll have a follow-up appointment with the neurosurgeon. This will usually be about 7 to 14 days after the surgery. […] Your full recovery time will vary from four to six weeks, depending on how big your acoustic neuroma was and how long the surgical procedure lasted. […] If you opt for the Gamma Knife procedure, you’ll be able to go home within an hour of completing the treatment. And, you’ll be able to return to normal activities just 24 to 48 hours after the treatment. […] Based on your condition, we’ll be able to pinpoint the right course of treatment for you. Given our success with the Gamma Knife treatment, this less invasive course may be better for your tumor. […] No matter what you choose, we’d be happy to help you find out the best choice of treatment whether it be the Gamma Knife or vestibular schwannoma surgery.

• #28 Schwannomas & Vestibular Schwannomas | the holistic neurosurgeon

  https://www.theholisticneurosurgeon.com/schwannomas-vestibular-schwannomas

  Hydrocephalus is a build up of the CSF on the brain which can occur before or after surgery as a consequence of the tumour or its treatment. If this occurs you may require a temporary or permanent drain (shunt) placed into the brain. […] Recovery from this operation is slow and steady. It will take approximately six to twelve weeks. Some people may take longer. […] If you drive you can continue to do so after your operation and you do not need to notify the DVLA with this type of tumour. […] Return to work will depend on what sort of work you do and when you feel able. […] Follow-up scans will be arranged for a minimum of 10 years following surgery to check for any re-growth. […] Radio-surgery is usually offered to patients with small but growing tumours, as an alternative or adjunct to surgery. This can be delivered in one dose (single fraction) or several doses (fractionated radiotherapy) which can be a course delivered over a period of up to six weeks on a daily basis).

• #29 Vestibular Schwannoma Treatments | Targeting Cancer AU & NZ

  https://www.targetingcancer.com.au/treatment-by-cancer-type/vestibular-schwannoma/

  The best person to talk to about radiation therapy for vestibular schwannomas is a radiation oncologist. […] You can ask your doctor for a referral to a radiation oncologist to learn if radiation therapy is an option for you. […] The type of treatment a person gets is worked out by a team of doctors and health professionals often called a Multidisciplinary Team. […] There are a few ways to treat vestibular schwannomas. These include observation, surgery, or radiation therapy. […] For larger schwannomas and younger people, surgery is preferred. […] Radiation therapy can be used to treat vestibular schwannoma. The aim of treatment is to stop the tumour growing and protect the nerve. […] Stereotactic treatments have success rates of between 91 to 100% 10 years after treatment. […] Before starting treatment, your radiation oncologist will talk to you about side effects and answer your questions.

• #30 Vestibular Schwannoma Treatments | Targeting Cancer AU & NZ

  https://www.targetingcancer.com.au/treatment-by-cancer-type/vestibular-schwannoma/

  The best person to talk to about radiation therapy for vestibular schwannomas is a radiation oncologist. […] You can ask your doctor for a referral to a radiation oncologist to learn if radiation therapy is an option for you. […] The type of treatment a person gets is worked out by a team of doctors and health professionals often called a Multidisciplinary Team. […] There are a few ways to treat vestibular schwannomas. These include observation, surgery, or radiation therapy. […] For larger schwannomas and younger people, surgery is preferred. […] Radiation therapy can be used to treat vestibular schwannoma. The aim of treatment is to stop the tumour growing and protect the nerve. […] Stereotactic treatments have success rates of between 91 to 100% 10 years after treatment. […] Before starting treatment, your radiation oncologist will talk to you about side effects and answer your questions.

• #31 Acoustic Neuroma Treatment & Management: Medical Therapy, Surgical Therapy, Preoperative Considerations

  https://emedicine.medscape.com/article/882876-treatment

  Acoustic neuromas are managed in one of the following three ways: (1) surgical excision of the tumor, (2) arresting of tumor growth using stereotactic radiation therapy, or (3) careful serial observation. […] Intervention is indicated when tumors exhibit significant growth, which is generally considered greater than 2 mm per year. Options include either microsurgery or radiosurgery, and optimal therapy is dependent on such factors as tumor size, patient age, and hearing status. […] Stereotactic radiosurgery has emerged as an alternative to microsurgery for selected patients with acoustic neuroma. Stereotactic radiation therapy makes use of one of several radiation sources and is administered using a variety of different machines with proprietary names (eg, Gamma Knife, CyberKnife, Brainlab).

• #32 Radiation Therapy for Acoustic Neuroma (Vestibular Schwannoma) | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/cancer-care/types/acoustic-neuroma/treatment/radiation-therapy-acoustic-neuroma

  Radiation therapy can shrink or kill acoustic neuroma (vestibular schwannoma) cells. […] We may recommend radiation based on your symptoms, the size or shape of your tumor, your age, and other health problems. Radiation may also be recommended if your tumor is in a location that makes it difficult to remove with surgery, or if we are not able to remove the entire tumor with surgery. […] We use three types of radiation for acoustic neuroma: […] Stereotactic radiosurgery is a highly precise, minimally invasive way of delivering radiation directly to a tumor with little or no impact on surrounding structures. […] Intensity-modulated radiation therapy (IMRT), which uses sophisticated software and 3-D images from CT scans to focus high doses of radiation directly to your tumor. […] Image-guided radiation therapy (IGRT), which uses real-time imaging with CT scans or x-rays during radiation therapy to help ensure ideal positioning and lack of motion during treatment. IGRT enables your treatment team to deliver radiation with great accuracy.

• #33 Acoustic Neuroma Treatment & Management: Medical Therapy, Surgical Therapy, Preoperative Considerations

  https://emedicine.medscape.com/article/882876-treatment

  Acoustic neuromas are managed in one of the following three ways: (1) surgical excision of the tumor, (2) arresting of tumor growth using stereotactic radiation therapy, or (3) careful serial observation. […] Intervention is indicated when tumors exhibit significant growth, which is generally considered greater than 2 mm per year. Options include either microsurgery or radiosurgery, and optimal therapy is dependent on such factors as tumor size, patient age, and hearing status. […] Stereotactic radiosurgery has emerged as an alternative to microsurgery for selected patients with acoustic neuroma. Stereotactic radiation therapy makes use of one of several radiation sources and is administered using a variety of different machines with proprietary names (eg, Gamma Knife, CyberKnife, Brainlab).

• #34 Expert guidance for vestibular schwannomas’ complex treatment decisions – Mayo Clinic

  https://www.mayoclinic.org/medical-professionals/neurology-neurosurgery/news/expert-guidance-for-vestibular-schwannomas-complex-treatment-decisions/mac-20534886

  „Hearing loss is likely to progress with this approach, even if the tumor doesn’t grow,” Dr. Link says. […] If tumor growth is confirmed, Mayo Clinic generally recommends radiosurgery or microsurgery. Radiosurgery is reserved for tumors measuring less than 2.5 cm. The options include Gamma Knife radiosurgery which Mayo Clinic has performed for more than 30 years as well as intensity-modulated therapy and proton therapy. […] „Radiosurgery doesn’t cure the tumor. The goal is to prevent tumor growth,” Dr. Link says. „Between 50% and 70% of patients retain serviceable hearing in the treated ear.” […] Microsurgery is the treatment of choice for large tumors associated with complications such as brainstem compression, hydrocephalus, trigeminal neuralgia or neuropathy. The procedure is performed with an operating microscope and intraoperative neural monitoring.

• #35 3 Innovative Acoustic Neuroma Treatment Options | MD Anderson Cancer Center

  https://www.mdanderson.org/cancer-types/acoustic-neuroma/acoustic-neuroma-treatment.html

  Surgery for acoustic neuromas is complex and delicate, and it requires a team of experts from several specialties. […] Your physician will recommend the best type of surgery for your specific condition. Approaches that can preserve hearing are available for some carefully selected patients most likely to benefit from these procedures. […] Stereotactic radiosurgery (SRS) is a non-invasive treatment that uses dozens of tiny radiation beams to accurately target tumors with a single high dose of radiation. […] For the one-day procedure, the patient is fitted with a headframe by a neurosurgeon, and a special MRI scan is performed. Then the care team creates a customized treatment plan. […] Sometimes called watchful waiting, this approach may be used for some patients with small or slow-growing acoustic neuromas. Instead of undergoing immediate treatment, the patient undergoes regular monitoring for tumor growth and progression. Treatment will begin only if the disease progresses to a set point. […] For acoustic neuroma, active surveillance includes regular MRI exams to track tumor growth and audiograms to monitor hearing status.

• #36 Vestibular Schwannoma Treatments | Targeting Cancer AU & NZ

  https://www.targetingcancer.com.au/treatment-by-cancer-type/vestibular-schwannoma/

  The best person to talk to about radiation therapy for vestibular schwannomas is a radiation oncologist. […] You can ask your doctor for a referral to a radiation oncologist to learn if radiation therapy is an option for you. […] The type of treatment a person gets is worked out by a team of doctors and health professionals often called a Multidisciplinary Team. […] There are a few ways to treat vestibular schwannomas. These include observation, surgery, or radiation therapy. […] For larger schwannomas and younger people, surgery is preferred. […] Radiation therapy can be used to treat vestibular schwannoma. The aim of treatment is to stop the tumour growing and protect the nerve. […] Stereotactic treatments have success rates of between 91 to 100% 10 years after treatment. […] Before starting treatment, your radiation oncologist will talk to you about side effects and answer your questions.

• #37 Treatment for vestibular schwannoma: Systematic review and single arm meta-analysis – PubMed

  https://pubmed.ncbi.nlm.nih.gov/34973662/

  Objective: Vestibular schwannoma is a benign tumor in the schwannoma cells of the 8th cranial nerve. It causes symptoms like tinnitus, vertigo and end up with loss of hearing so the appropriate treatment is very important. There are many treatment techniques including conservative, surgery and radiosurgery. We aimed to systematically review and single arm meta-analysis the different treatment techniques of vestibular schwannoma. […] A total of 35 clinical trials studies were included in the final analysis. The pooled proportion of stable hearing capability in patients receiving gamma knife radiosurgery (GKRS) was 64% (95% CI: 52%-74%). GKRS favored increased hearing capability 10% (95% CI: 7%-16%). Regarding tumor size, GKRS is the most protective method 53% (95% CI: 37%-69%). Complications occurred most commonly in single fractional linac stereotactic radiosurgery (SFSRT) 37% (95% CI: 12%-72%). […] Our analysis suggested gamma knife radiosurgery could be the most ideal treatment for vestibular schwannoma based on stabilizing hearing capability, increasing hearing capability, decreasing tumor size and complications.

• #38 Vestibular Schwannoma | Brain tumour (primary) | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/brain-tumours/types/vestibular-schwannoma

  There are different types of surgery that you can have. A common type is removing the tumour through a hole in your skull. This is usually a small cut above your ear or behind your ear. […] To remove the tumour, it may be necessary to cut the hearing and balance nerve on the side where the tumour is. Your neurosurgeon will discuss the options with you. […] You might have side effects after the operation. The side effects can include: […] For small tumours, you may have stereotactic radiotherapy or radiosurgery. Both treatments target high doses of radiotherapy to the tumour. […] You might have targeted radiotherapy alone, or after surgery if the surgeon was unable to completely remove the tumour. […] You might have side effects such as hearing loss and facial weakness after targeted radiotherapy.

• #39 Vestibular Schwannoma (Acoustic Neuroma) – Facial Palsy UK

  https://www.facialpalsy.org.uk/causesanddiagnoses/vestibular-schwannoma-acoustic-neuroma/

  Radiation therapy is used to treat small and medium-sized vestibular schwannomas and the goal is to stop the growth of the tumour. This treatment works by delivering controlled high-energy rays of radiation to the tumour: the aim is to damage the cells so that they are unable to divide and reproduce. […] The results are not immediate but develop gradually over time as the tumour stops growing or shrinks in size. It does not remove the tumour and therefore periodic MRI scans are required throughout the patients lifetime to monitor any changes.

• #40 A Review of Drug Therapy in Vestibular Schwannoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7802892/

  Vestibular schwannomas (VSs, also known as acoustic neuromas) are benign intracranial tumors commonly managed with observation, surgery, and radiotherapy. […] There is currently no approved pharmacotherapy for VS patients, which is why we conducted a detailed search of relevant literature from PubMed and Web of Science to explore recent advances and experiences in drug therapy. […] Conventional chemotherapeutic agents are characterized by neurotoxicity or ototoxicity, poor effect on slow-growing tumors, and may induce new mutations in patients who have lost tumor suppressor function, and therefore are unsuitable for treating VSs. […] Along with the well-investigated molecular pathophysiology of VS and the increasingly accessible technology such as drug repositioning platform, many molecular targeted inhibitors have been identified and shown certain therapeutic effects in preclinical experiments or clinical trials.

• #41 A Review of Drug Therapy in Vestibular Schwannoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7802892/

  This dual inhibition of tumorigenesis and angiogenesis potentializes imatinib in the treatment of VS. […] Bevacizumab (5mg/kg/2 week) treatment can lead to tumor shrinkage in up to 90% of cases patients, as well as durable hearing response in over half of cases. […] Although bevacizumab has achieved promising and satisfactory results in progressive and large tumors, its therapeutic effect seems to have population differences. […] The volumetric response to bevacizumab therapy can be predicted by the mean apparent diffusion coefficient at baseline, while hearing improvement is inversely correlated with the baseline plasma hepatocyte growth factor (HGF) level. […] The role of bevacizumab in NF2-VS has been well documented. […] Targeted therapy has shown efficacy in both sporadic VS and NF2-VS. […] Further multidisciplinary cooperation will help to choose the best treatment plan for individual patients and maximize the protection of nerve function.

• #42 A Review of Drug Therapy in Vestibular Schwannoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7802892/

  This dual inhibition of tumorigenesis and angiogenesis potentializes imatinib in the treatment of VS. […] Bevacizumab (5mg/kg/2 week) treatment can lead to tumor shrinkage in up to 90% of cases patients, as well as durable hearing response in over half of cases. […] Although bevacizumab has achieved promising and satisfactory results in progressive and large tumors, its therapeutic effect seems to have population differences. […] The volumetric response to bevacizumab therapy can be predicted by the mean apparent diffusion coefficient at baseline, while hearing improvement is inversely correlated with the baseline plasma hepatocyte growth factor (HGF) level. […] The role of bevacizumab in NF2-VS has been well documented. […] Targeted therapy has shown efficacy in both sporadic VS and NF2-VS. […] Further multidisciplinary cooperation will help to choose the best treatment plan for individual patients and maximize the protection of nerve function.

• #43 Guidelines on the Management of Patients with Vestibular Schwannoma

  https://www.cns.org/guidelines/management-patients-vestibular-schwannoma/9-emerging-therapies-treatment-of-patients-with-ve

  No part of this manuscript has been published or submitted for publication elsewhere. […] It is recommended that bevacizumab be administered to radiographically reduce the size or prolong tumor stability in patients with NF2 without surgical options. […] It is recommended bevacizumab be administered to improve hearing or prolong time to hearing loss in patients with NF2 without surgical options. […] Lapatinib may be considered for use in reducing VS size and improvement in hearing in NF2. […] Level 3: It is recommended that aspirin administration may be considered for use in patients undergoing observation of their VSs. […] Perioperative treatment with nimodipine (or with addition of hydroxyethyl starch) should be considered to improve postoperative facial nerve outcomes and may improve hearing outcomes.

• #44 A Review of Drug Therapy in Vestibular Schwannoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7802892/

  This dual inhibition of tumorigenesis and angiogenesis potentializes imatinib in the treatment of VS. […] Bevacizumab (5mg/kg/2 week) treatment can lead to tumor shrinkage in up to 90% of cases patients, as well as durable hearing response in over half of cases. […] Although bevacizumab has achieved promising and satisfactory results in progressive and large tumors, its therapeutic effect seems to have population differences. […] The volumetric response to bevacizumab therapy can be predicted by the mean apparent diffusion coefficient at baseline, while hearing improvement is inversely correlated with the baseline plasma hepatocyte growth factor (HGF) level. […] The role of bevacizumab in NF2-VS has been well documented. […] Targeted therapy has shown efficacy in both sporadic VS and NF2-VS. […] Further multidisciplinary cooperation will help to choose the best treatment plan for individual patients and maximize the protection of nerve function.

• #45 A Review of Drug Therapy in Vestibular Schwannoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7802892/

  All of these proposed sites are potential therapeutic targets of VS. […] The transfer of the phosphate groups on adenosine triphosphate (ATP) to determined target proteins is catalyzed by kinases, which are the primary mediators in cell signal transduction that regulate cell differentiation, growth, migration, and apoptosis. […] A number of RTKs have been shown to be associated with VS, such as ErbB, platelet-derived growth factor (PDGF), fibroblasts growth factor (FGF), insulin-like growth factor-1 (IGF-1), and vascular endothelial growth factor (VEGF). […] Imatinib mesylate (STI571) is an inhibitor of the BCR-ABL fusion kinase designed to treat chronic myelogenous leukemia (CML). […] Moreover, corneal angiogenesis assay revealed that imatinib has an inhibitory effect for angiogenesis in both sporadic and NF2-related VS.

• #46 A Review of Drug Therapy in Vestibular Schwannoma | DDDT

  https://www.dovepress.com/a-review-of-drug-therapy-in-vestibular-schwannoma-peer-reviewed-fulltext-article-DDDT

  All of these proposed sites are potential therapeutic targets of VS. […] The transfer of the phosphate groups on adenosine triphosphate (ATP) to determined target proteins is catalyzed by kinases, which are the primary mediators in cell signal transduction that regulate cell differentiation, growth, migration, and apoptosis. […] A number of RTKs have been shown to be associated with VS, such as ErbB, platelet-derived growth factor (PDGF), fibroblasts growth factor (FGF), insulin-like growth factor-1 (IGF-1), and vascular endothelial growth factor (VEGF). […] Imatinib mesylate (STI571) is an inhibitor of the BCR-ABL fusion kinase designed to treat chronic myelogenous leukemia (CML). […] In vitro studies using the immortalized NF2-null VS cell line HEI-193 showed that imatinib mesylate inhibits the activation of c-KIT, PDGFR-, and PDGFR- and its downstream signaling pathways, leading to increased apoptosis, cell cycle arrest, and decreased cell viability in a dose-dependent manner.

• #47 A Review of Drug Therapy in Vestibular Schwannoma | DDDT

  https://www.dovepress.com/a-review-of-drug-therapy-in-vestibular-schwannoma-peer-reviewed-fulltext-article-DDDT

  All of these proposed sites are potential therapeutic targets of VS. […] The transfer of the phosphate groups on adenosine triphosphate (ATP) to determined target proteins is catalyzed by kinases, which are the primary mediators in cell signal transduction that regulate cell differentiation, growth, migration, and apoptosis. […] A number of RTKs have been shown to be associated with VS, such as ErbB, platelet-derived growth factor (PDGF), fibroblasts growth factor (FGF), insulin-like growth factor-1 (IGF-1), and vascular endothelial growth factor (VEGF). […] Imatinib mesylate (STI571) is an inhibitor of the BCR-ABL fusion kinase designed to treat chronic myelogenous leukemia (CML). […] In vitro studies using the immortalized NF2-null VS cell line HEI-193 showed that imatinib mesylate inhibits the activation of c-KIT, PDGFR-, and PDGFR- and its downstream signaling pathways, leading to increased apoptosis, cell cycle arrest, and decreased cell viability in a dose-dependent manner.

• #48 A Review of Drug Therapy in Vestibular Schwannoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7802892/

  All of these proposed sites are potential therapeutic targets of VS. […] The transfer of the phosphate groups on adenosine triphosphate (ATP) to determined target proteins is catalyzed by kinases, which are the primary mediators in cell signal transduction that regulate cell differentiation, growth, migration, and apoptosis. […] A number of RTKs have been shown to be associated with VS, such as ErbB, platelet-derived growth factor (PDGF), fibroblasts growth factor (FGF), insulin-like growth factor-1 (IGF-1), and vascular endothelial growth factor (VEGF). […] Imatinib mesylate (STI571) is an inhibitor of the BCR-ABL fusion kinase designed to treat chronic myelogenous leukemia (CML). […] Moreover, corneal angiogenesis assay revealed that imatinib has an inhibitory effect for angiogenesis in both sporadic and NF2-related VS.

• #49 A Review of Drug Therapy in Vestibular Schwannoma | DDDT

  https://www.dovepress.com/a-review-of-drug-therapy-in-vestibular-schwannoma-peer-reviewed-fulltext-article-DDDT

  Nilotinib (AMN107) is a second-generation RTK inhibitor with a target profile similar to that of imatinib, but has increased potency, decreased toxicity, and greater tissue permeability, making it easier to penetrate the blood-brain barrier. […] Nilotinib has been shown to inhibit cell proliferation more effectively than imatinib in a primary human schwannoma cell in vitro model, indicating that this compound has a therapeutic effect on merlin-deficient tumors. […] The VEGFR family mainly includes VEGFR-1 (Flt-1), VEGFR-2 (Flk-1/KDR), and VEGFR-3 (Flt-4), which are important regulators of physiological or pathological angiogenesis. […] Studies have shown that the concentration of VEGF and VEGFR-1 is related to the growth rate of VS, which warrants further research regarding the anti-VEGF monoclonal antibody bevacizumab for VS treatment.

• #50 A Review of Drug Therapy in Vestibular Schwannoma | DDDT

  https://www.dovepress.com/a-review-of-drug-therapy-in-vestibular-schwannoma-peer-reviewed-fulltext-article-DDDT

  Nilotinib (AMN107) is a second-generation RTK inhibitor with a target profile similar to that of imatinib, but has increased potency, decreased toxicity, and greater tissue permeability, making it easier to penetrate the blood-brain barrier. […] Nilotinib has been shown to inhibit cell proliferation more effectively than imatinib in a primary human schwannoma cell in vitro model, indicating that this compound has a therapeutic effect on merlin-deficient tumors. […] The VEGFR family mainly includes VEGFR-1 (Flt-1), VEGFR-2 (Flk-1/KDR), and VEGFR-3 (Flt-4), which are important regulators of physiological or pathological angiogenesis. […] Studies have shown that the concentration of VEGF and VEGFR-1 is related to the growth rate of VS, which warrants further research regarding the anti-VEGF monoclonal antibody bevacizumab for VS treatment.

• #51 New experimental treatment can stop the growth of schwannoma tumours – University of Plymouth

  https://www.plymouth.ac.uk/news/new-experimental-treatment-can-stop-the-growth-of-schwannoma-tumours

  Nowe eksperymentalne leczenie może zatrzymać wzrost guzów schwannoma. Badacze pokazali, że po zaledwie 21 dniach podawania leków wzrost guza może być silnie i znacząco zmniejszony. Dwa nowe leki podawane doustnie mogą nie tylko blokować wzrost, ale także zmniejszać rozmiar guza typu schwannoma. Leczenie obu typów guzów jest trudne, a chirurgia jest obecnie główną metodą, ale niesie ze sobą wysokie ryzyko uszkodzenia otaczających normalnych tkanek nerwowych. […] Zespół naukowców skoncentrował się na szlaku sygnalizacyjnym Hippo, który normalnie kontroluje rozmiar narządów w ludzkich tkankach i komórkach, ale jest zaburzony w wielu typach nowotworów. […] Po zaledwie 21 dniach podawania leków wzrost guza może być silnie i znacząco zmniejszony. […] Leczenie inhibitorami szlaku Hippo (nazywanymi VT1 i VT2 w badaniu) faktycznie spowodowało śmierć komórek guza i ogólną redukcję rozmiaru guza.

• #52 A Critical Overview of Targeted Therapies for Vestibular Schwannoma

  https://www.mdpi.com/1422-0067/23/10/5462

  Currently, the mainstays of management are observation, surgery, and radiosurgery. Surgery with facial and auditory monitoring remains the only curative treatment for growing VSs of all sizes. Stereotactic radiosurgery is considered as a widely accepted treatment option for small-sized VSs. For larger tumors, combined treatment strategies are mostly recommended. In particular, gamma knife radiosurgery (GKRS) has become an accepted treatment for VS. However, additional treatment is needed for some refractory cases. Tumor volume ≥15 cm³ is a significant factor predicting poor tumor control following GKRS. There is no approved medical therapy for VS. For refractory VS with high risks of surgical treatment or GKRS, medical therapies that can slow tumor growth are urgently needed. […] Bevacizumab may be considered as first-line medical therapy for rapidly growing VS. In a recent meta-analysis, the median treatment duration was 16 months. Recently, the first phase III randomized clinical trial using bevacizumab was conducted in Japan. Furthermore, progressive sporadic VS also exhibited significant tumor shrinkage after bevacizumab administration.

• #53 Schwannoma gene therapy by adeno-associated virus delivery of the pore-forming protein Gasdermin-D | Cancer Gene Therapy

  https://www.nature.com/articles/s41417-018-0077-3

  Schwannomas are peripheral nerve sheath tumors associated with three genetically distinct disease entities, namely sporadic schwannoma, neurofibromatosis type-2, and schwannomatosis. […] The primary treatment is operative resection that itself can cause neurologic damage and is at times contra-indicated due to tumor location. […] Given their homogenous Schwann-lineage cellular composition, schwannomas are appealing targets for gene therapy. […] we have demonstrated that AAV1-P0-GSDMDNterm injection into intra-sciatic schwannomas reduces the growth of these tumors and resolves tumor-associated pain without causing neurologic damage. […] This AAV1-P0-GSDMDNterm vector holds promise for clinical treatment of schwannomas via direct intra-tumoral injection.

• #54 Schwannoma: What It Is, Causes, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17877-schwannoma

  Treatment for schwannoma depends on where the tumor is in your body and how quickly it’s growing. […] Some treatment options include: […] Observation/watch and wait: If the tumor is benign, growing very slowly and you’re experiencing no or very mild symptoms, your healthcare provider may recommend closely monitoring it instead of treating it. […] Surgery: If the tumor is growing more quickly or causing other problems, your healthcare provider may recommend removing it with surgery. […] Radiation therapy: Stereotactic radiosurgery (SRS) uses many precisely focused radiation beams to destroy tumors. […] Malignant (cancerous) schwannomas may be treated with immunotherapy and chemotherapy medications as well.

• #55 Schwannoma: Treatment, Procedure, Cost, Recovery, Side Effects And More

  https://www.lybrate.com/topic/schwannoma

  Synonyms for Schwannoma are Neurilemmoma, neurilemoma, neurinoma, neurolemmoma, Schwann cell tumour. […] Treatment depends on where the tumour is in your body and whether it is benign or malignant (cancerous). […] The main treatment for schwannoma is surgery to remove the tumour. […] You might also have radiotherapy and chemotherapy if you have a malignant tumour. […] Treatment of malignant schwannoma. These tumours can be difficult to treat. The main treatment is surgery, where the surgeon will try to remove as much of the tumour as possible and the surrounding tissue. […] Radiotherapy might also be used before or after surgery to try to shrink the tumour or to reduce the risk of it coming back. […] Malignant schwannomas don’t respond very well to chemotherapy. […] Chemotherapy may be used to try to shrink the tumour or to keep it at bay, but it is usually unlikely to cure it.

• #56 Neurofibrosarcoma and Schwannoma

  https://www.webmd.com/cancer/neurofibrosarcoma-and-schwannoma

  Schwannomas may not need treatment if theyre not causing any symptoms. However, your doctor will monitor it closely for changes. You might need surgery if the tumor is growing quickly or is pressing on a nerve, causing pain or other problems. […] In some cases, your doctor could recommend radiation therapy. This could happen if the tumor is too close to vital blood vessels or nerves and surgery could cause complications. Called stereotactic radiotherapy (SRS), this type of radiation focuses radiation beams on the tumor to destroy it. […] Schwannomas are rarely cancerous, but if they are malignant, the doctor may treat them with immunotherapy and chemotherapy, in addition to radiation or surgery. […] The most common treatment for neurofibrosarcomas is to remove them with surgery. Your doctor would remove the tumor and as much of the tissue around it as needed.

• #57 New experimental treatment can stop the growth of schwannoma tumours – University of Plymouth

  https://www.plymouth.ac.uk/news/new-experimental-treatment-can-stop-the-growth-of-schwannoma-tumours

  Nowe eksperymentalne leczenie może zatrzymać wzrost guzów schwannoma. Badacze pokazali, że po zaledwie 21 dniach podawania leków wzrost guza może być silnie i znacząco zmniejszony. Dwa nowe leki podawane doustnie mogą nie tylko blokować wzrost, ale także zmniejszać rozmiar guza typu schwannoma. Leczenie obu typów guzów jest trudne, a chirurgia jest obecnie główną metodą, ale niesie ze sobą wysokie ryzyko uszkodzenia otaczających normalnych tkanek nerwowych. […] Zespół naukowców skoncentrował się na szlaku sygnalizacyjnym Hippo, który normalnie kontroluje rozmiar narządów w ludzkich tkankach i komórkach, ale jest zaburzony w wielu typach nowotworów. […] Po zaledwie 21 dniach podawania leków wzrost guza może być silnie i znacząco zmniejszony. […] Leczenie inhibitorami szlaku Hippo (nazywanymi VT1 i VT2 w badaniu) faktycznie spowodowało śmierć komórek guza i ogólną redukcję rozmiaru guza.

• #58 Schwannoma: Treatment, Procedure, Cost, Recovery, Side Effects And More

  https://www.lybrate.com/topic/schwannoma

  Regrowth (recurrence) of a schwannoma is unlikely following the complete removal of the tumor by surgery. […] If a schwannoma comes back in the same place, it may not have been completely removed by surgery. […] Even a microscopic piece of the tumor that remains in the body may be enough to allow it to regrow. […] Because schwannomas are almost always benign, it is very unlikely for a schwannoma to return in another part of the body (metastasize).

• #59 Schwannoma | Expert Surgeon | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/schwannoma

  For patients with a small and incidentally found schwannoma, treatment may not be necessary. Since the schwannoma is benign and slow growing, it may be preferable to simply observe the tumor over time with periodic imaging scans. […] The prognosis for a benign schwannoma is typically excellent. Surgery is often curative, and most individuals go on to live their normal lives after treatment. […] Regular monitoring is crucial for managing schwannomas and detecting any signs of malignant transformation early.

• #60 Acoustic Neuroma Treatment | Vestibular Schwannoma | Duke Health

  https://www.dukehealth.org/treatments/ear-nose-and-throat/acoustic-neuroma

  More comprehensive treatments to address the tumor itself include: […] The best hospitals for acoustic neuroma surgery have surgeons like ours who are specifically trained and highly experienced in removing acoustic neuromas. […] Image-guided radiation therapy, including stereotactic radiosurgery, targets the tumor while preserving healthy brain tissue. […] Medications are sometimes used in conjunction with radiation therapy or surgery. […] Beyond treating the tumor itself, we have a wide range of options to treat the possible symptoms of an acoustic neuroma, including hearing loss, balance problems, and facial weakness or facial paralysis. […] This special form of physical therapy trains your body and brain to make up for inner-ear dysfunction, helps you feel steadier on your feet, and relieves or reduces disabling symptoms. […] This surgery may be recommended if you experience total or near-total loss of your ability to show facial expression.

• #61 Acoustic Neuroma Treatment & Surgery (Vestibular Schwannoma)

  https://health.ucsd.edu/care/ent/acoustic-neuroma/treatment/

  The middle fossa approach requires considerable skill and experience. Our acoustic neuroma surgeons, Drs. Rick Friedman and Marc Schwartz, have worked together for more than two decades to treat acoustic neuromas. They have a high success rate of preserving hearing with middle fossa microsurgery. […] UC San Diego Health offers an inpatient osteopathic manual medicine consultation service to acoustic neuroma patients after surgery. […] Vestibular therapy involves exercises to reduce dizziness, improve balance and promote faster recovery and return to activity. […] Preservation of hearing after treatment for an acoustic neuroma depends on several factors, including the size and location of the tumor, the treatment method, and the baseline hearing level before treatment. At UC San Diego Health, we have a high rate of hearing preservation with the middle fossa surgical approach.

• #62 Acoustic Neuroma Treatment | Vestibular Schwannoma | Duke Health

  https://www.dukehealth.org/treatments/ear-nose-and-throat/acoustic-neuroma

  More comprehensive treatments to address the tumor itself include: […] The best hospitals for acoustic neuroma surgery have surgeons like ours who are specifically trained and highly experienced in removing acoustic neuromas. […] Image-guided radiation therapy, including stereotactic radiosurgery, targets the tumor while preserving healthy brain tissue. […] Medications are sometimes used in conjunction with radiation therapy or surgery. […] Beyond treating the tumor itself, we have a wide range of options to treat the possible symptoms of an acoustic neuroma, including hearing loss, balance problems, and facial weakness or facial paralysis. […] This special form of physical therapy trains your body and brain to make up for inner-ear dysfunction, helps you feel steadier on your feet, and relieves or reduces disabling symptoms. […] This surgery may be recommended if you experience total or near-total loss of your ability to show facial expression.

• #63 Guidelines on the Management of Patients with Vestibular Schwannoma

  https://www.cns.org/guidelines/management-patients-vestibular-schwannoma/9-emerging-therapies-treatment-of-patients-with-ve

  Preoperative vestibular rehabilitation is recommended to aid in postoperative mobility after VS surgery. […] Preoperative gentamicin ablation of the vestibular apparatus should be considered to improve postoperative mobility after VS surgery. […] Endoscopic assistance is a surgical technique that the surgeon may choose to use in order to aid in visualization. […] Bevacizumab results in 50% improved hearing and 50% objective radiographic shrinkage of the VSs in NF2 patients but is not effective in all patients. […] Recommendations that can be made include bevacizumab may be administered to radiographically reduce the size or prolong tumor stability in patients with NF2 without surgical options. […] Aspirin use may be useful in patients with VSs undergoing observation; however, this study should be validated in prospective randomized trials that should be achievable.

• #64 Guidelines on the Management of Patients with Vestibular Schwannoma

  https://www.cns.org/guidelines/management-patients-vestibular-schwannoma/9-emerging-therapies-treatment-of-patients-with-ve

  Preoperative vestibular rehabilitation is recommended to aid in postoperative mobility after VS surgery. […] Preoperative gentamicin ablation of the vestibular apparatus should be considered to improve postoperative mobility after VS surgery. […] Endoscopic assistance is a surgical technique that the surgeon may choose to use in order to aid in visualization. […] Bevacizumab results in 50% improved hearing and 50% objective radiographic shrinkage of the VSs in NF2 patients but is not effective in all patients. […] Recommendations that can be made include bevacizumab may be administered to radiographically reduce the size or prolong tumor stability in patients with NF2 without surgical options. […] Aspirin use may be useful in patients with VSs undergoing observation; however, this study should be validated in prospective randomized trials that should be achievable.

• #65 Schwannoma | Other conditions | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/other-conditions/schwannoma

  Treatment depends on where the tumour is in your body and your symptoms. Your specialist may monitor you carefully at first rather than suggest treatment. They will see you regularly and check any symptoms you have. They will examine you at each appointment and you may have some tests. […] The main treatment for schwannoma is surgery to remove the tumour. The type of surgery you have depends on where in the body the tumour is. […] You may have stereotactic radiotherapy or radiosurgery. Both treatments target high doses of radiotherapy to the tumour. […] You will also have treatment to control any pain you have. You might see a doctor who specialises in pain control. […] The treatment you have may include: regular check-up appointments with tests – these may include, MRI scans hearing tests and eye tests, surgery, targeted radiotherapy, pain control. […] Controlling the pain is very important in this condition. Removing the schwannoma by surgery can also help relieve the pain.

• #66 Schwannoma | Other conditions | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/other-conditions/schwannoma

  Treatment depends on where the tumour is in your body and your symptoms. Your specialist may monitor you carefully at first rather than suggest treatment. They will see you regularly and check any symptoms you have. They will examine you at each appointment and you may have some tests. […] The main treatment for schwannoma is surgery to remove the tumour. The type of surgery you have depends on where in the body the tumour is. […] You may have stereotactic radiotherapy or radiosurgery. Both treatments target high doses of radiotherapy to the tumour. […] You will also have treatment to control any pain you have. You might see a doctor who specialises in pain control. […] The treatment you have may include: regular check-up appointments with tests – these may include, MRI scans hearing tests and eye tests, surgery, targeted radiotherapy, pain control. […] Controlling the pain is very important in this condition. Removing the schwannoma by surgery can also help relieve the pain.

• #67 Vestibular schwannoma (acoustic neuroma) | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/brain-tumour/acoustic-neuroma

  Your treatment may depend on: […] If treatment is needed, the main treatments for vestibular schwannoma are: […] A team of specialists will plan your treatment. Your specialist doctor and nurse will explain the aims of your treatment and what it involves. […] You may be given a choice of treatment options. […] The aim of any treatment is to control the tumour and stop it growing or remove it. […] How treatment might affect your hearing varies depending on the type of treatment and your individual situation. […] Active monitoring means regularly checking the tumour to find out whether it is growing. […] If the tumour is small, your doctor may suggest monitoring the tumour for growth. […] Radiotherapy uses high-energy rays to destroy the tumour cells. […] A vestibular schwannoma is usually treated with a type of radiotherapy called stereotactic radiotherapy (SRT).

• #68 Vestibular Schwannoma | Brain tumour (primary) | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/brain-tumours/types/vestibular-schwannoma

  You have regular appointments with your doctor or nurse after treatment finishes. Your doctor examines you at each appointment. They ask how you are feeling, whether you have had any symptoms or side effects, and if you are worried about anything. […] Doctors are always trying to improve the diagnosis and treatment of brain tumours. As part of your treatment, your doctor might ask you to take part in a clinical trial. This might be to test a new treatment or look at different combinations of existing treatments.

• #69 Schwannomas & Vestibular Schwannomas | the holistic neurosurgeon

  https://www.theholisticneurosurgeon.com/schwannomas-vestibular-schwannomas

  Hydrocephalus is a build up of the CSF on the brain which can occur before or after surgery as a consequence of the tumour or its treatment. If this occurs you may require a temporary or permanent drain (shunt) placed into the brain. […] Recovery from this operation is slow and steady. It will take approximately six to twelve weeks. Some people may take longer. […] If you drive you can continue to do so after your operation and you do not need to notify the DVLA with this type of tumour. […] Return to work will depend on what sort of work you do and when you feel able. […] Follow-up scans will be arranged for a minimum of 10 years following surgery to check for any re-growth. […] Radio-surgery is usually offered to patients with small but growing tumours, as an alternative or adjunct to surgery. This can be delivered in one dose (single fraction) or several doses (fractionated radiotherapy) which can be a course delivered over a period of up to six weeks on a daily basis).

• #70 Vestibular Schwannoma (Acoustic Neuroma) – Facial Palsy UK

  https://www.facialpalsy.org.uk/causesanddiagnoses/vestibular-schwannoma-acoustic-neuroma/

  Radiation therapy is used to treat small and medium-sized vestibular schwannomas and the goal is to stop the growth of the tumour. This treatment works by delivering controlled high-energy rays of radiation to the tumour: the aim is to damage the cells so that they are unable to divide and reproduce. […] The results are not immediate but develop gradually over time as the tumour stops growing or shrinks in size. It does not remove the tumour and therefore periodic MRI scans are required throughout the patients lifetime to monitor any changes.

• #71

  https://braintumourresearch.org/blogs/research-campaigning-news/step-taken-towards-non-surgical-treatment-for-schwannomas?srsltid=AfmBOoodWs-3IIII6DfwY7JCjN1L3Rty2Y20mRP1R0gsFdOpB2lYK67c

  The team at the Brain Tumour Research Centre of Excellence at the University of Plymouth has taken an exciting step forward in its work on neurofibromatosis type II (NF2). […] A paper from Professor David Parkinson and his team, published in the journal Brain, is progress in the development of a non-surgical treatment for NF2 patients who have developed schwannoma tumours, also known as acoustic neuroma. […] New treatments for schwannoma and other NF2-related tumours such as meningioma are urgently required. […] They demonstrated that two drugs, VT1 and VT2, successfully blocked this final stage and showed that in doing so, not only did schwannomas stop growing, but they also shrank in size. […] They concluded that the successful response to the drugs in their pre-clinical investigations provides a strong endorsement for early-phase clinical trials of both VT1 and VT2, potentially providing patients with schwannomas a successful alternative treatment to surgery and radiotherapy to manage their condition.

• #72

  https://braintumourresearch.org/blogs/research-campaigning-news/step-taken-towards-non-surgical-treatment-for-schwannomas?srsltid=AfmBOoodWs-3IIII6DfwY7JCjN1L3Rty2Y20mRP1R0gsFdOpB2lYK67c

  The team at the Brain Tumour Research Centre of Excellence at the University of Plymouth has taken an exciting step forward in its work on neurofibromatosis type II (NF2). […] A paper from Professor David Parkinson and his team, published in the journal Brain, is progress in the development of a non-surgical treatment for NF2 patients who have developed schwannoma tumours, also known as acoustic neuroma. […] New treatments for schwannoma and other NF2-related tumours such as meningioma are urgently required. […] They demonstrated that two drugs, VT1 and VT2, successfully blocked this final stage and showed that in doing so, not only did schwannomas stop growing, but they also shrank in size. […] They concluded that the successful response to the drugs in their pre-clinical investigations provides a strong endorsement for early-phase clinical trials of both VT1 and VT2, potentially providing patients with schwannomas a successful alternative treatment to surgery and radiotherapy to manage their condition.

• #73

  https://braintumourresearch.org/blogs/research-campaigning-news/step-taken-towards-non-surgical-treatment-for-schwannomas?srsltid=AfmBOoodWs-3IIII6DfwY7JCjN1L3Rty2Y20mRP1R0gsFdOpB2lYK67c

  The team at the Brain Tumour Research Centre of Excellence at the University of Plymouth has taken an exciting step forward in its work on neurofibromatosis type II (NF2). […] A paper from Professor David Parkinson and his team, published in the journal Brain, is progress in the development of a non-surgical treatment for NF2 patients who have developed schwannoma tumours, also known as acoustic neuroma. […] New treatments for schwannoma and other NF2-related tumours such as meningioma are urgently required. […] They demonstrated that two drugs, VT1 and VT2, successfully blocked this final stage and showed that in doing so, not only did schwannomas stop growing, but they also shrank in size. […] They concluded that the successful response to the drugs in their pre-clinical investigations provides a strong endorsement for early-phase clinical trials of both VT1 and VT2, potentially providing patients with schwannomas a successful alternative treatment to surgery and radiotherapy to manage their condition.

• #74

  https://braintumourresearch.org/blogs/research-campaigning-news/step-taken-towards-non-surgical-treatment-for-schwannomas?srsltid=AfmBOoodWs-3IIII6DfwY7JCjN1L3Rty2Y20mRP1R0gsFdOpB2lYK67c

  The team at the Brain Tumour Research Centre of Excellence at the University of Plymouth has taken an exciting step forward in its work on neurofibromatosis type II (NF2). […] A paper from Professor David Parkinson and his team, published in the journal Brain, is progress in the development of a non-surgical treatment for NF2 patients who have developed schwannoma tumours, also known as acoustic neuroma. […] New treatments for schwannoma and other NF2-related tumours such as meningioma are urgently required. […] They demonstrated that two drugs, VT1 and VT2, successfully blocked this final stage and showed that in doing so, not only did schwannomas stop growing, but they also shrank in size. […] They concluded that the successful response to the drugs in their pre-clinical investigations provides a strong endorsement for early-phase clinical trials of both VT1 and VT2, potentially providing patients with schwannomas a successful alternative treatment to surgery and radiotherapy to manage their condition.

• #75 Acoustic neuroma | The Brain Tumour Charity

  https://www.thebraintumourcharity.org/brain-tumour-diagnosis-treatment/types-of-brain-tumour-adult/acoustic-neuroma-vestibular-schwannoma/

  Clinical trials are being conducted using Bevacizumab, Everolimus and Lapatinib as potential options for treating vestibular schwannomas. […] Vestibular schwannomas very rarely return after surgery, but you may continue to have regular MRI scans. […] Even with treatment, symptoms such as tinnitus and hearing loss can persist. These symptoms will require additional treatment.

• #76 A Critical Overview of Targeted Therapies for Vestibular Schwannoma

  https://www.mdpi.com/1422-0067/23/10/5462

  Bevacizumab has recently been considered as the first-line medical therapy for rapidly growing vestibular schwannomas. Furthermore, new therapeutic strategies targeting the SH3PXD2A-HTRA1 fusion gene, several protein kinases, and the tumor microenvironment may be supportive for the mainstays of management. An immunotherapeutic approach may also be needed to control multiple tumor progression in the long term. In addition to the standard treatment strategy, including surgery and radiotherapy, these targeted medical therapies are needed for multiple and large tumors of VS. Multimodal therapy is required to manage patients with refractory VS.

• #77 Guidelines on the Management of Patients with Vestibular Schwannoma

  https://www.cns.org/guidelines/management-patients-vestibular-schwannoma/9-emerging-therapies-treatment-of-patients-with-ve

  Perioperative treatment with nimodipine (or with addition of hydroxyethyl starch) appears to improve postoperative facial nerve outcomes and may improve hearing outcomes. […] Prehab and preoperative gentamicin ablation may provide unique opportunities in improving postoperative mobility for patients undergoing VS surgery where they have preoperative vestibular function. […] Endoscopic use for VS surgery does not appear to worsen outcome or complications.

• #78 Early Nerve Tumor Treatment Prevents Problems, Study Finds

  https://newsroom.uvahealth.com/2024/11/12/vestibular_schwannomas/

  Patients with a small cranial nerve tumor that can cause hearing loss, vertigo, imbalance and ringing in the ears have typically been watched rather than proactively treated, as the risks of early intervention were thought to outweigh the benefits. […] However, even those patients benefit significantly from non-invasive stereotactic radiosurgery, a multicenter, international study led by UVA Health physicians has found. […] Their findings demonstrated that stereotactic radiosurgery a highly targeted form of radiation therapy can prevent small tumors from growing over time while at the same time sparing patients from potentially irreversible problems in the future. […] This study and our recent Vestibular Schwannoma International Study of Active Surveillance versus Stereotactic Radiosurgery [VISAS] trial demonstrate that radiosurgery affords effective and durable tumor control while more often avoiding the neurological complications that come from watching a vestibular schwannoma, Sheehan said.

• #79 A Critical Overview of Targeted Therapies for Vestibular Schwannoma

  https://www.mdpi.com/1422-0067/23/10/5462

  Bevacizumab has recently been considered as the first-line medical therapy for rapidly growing vestibular schwannomas. Furthermore, new therapeutic strategies targeting the SH3PXD2A-HTRA1 fusion gene, several protein kinases, and the tumor microenvironment may be supportive for the mainstays of management. An immunotherapeutic approach may also be needed to control multiple tumor progression in the long term. In addition to the standard treatment strategy, including surgery and radiotherapy, these targeted medical therapies are needed for multiple and large tumors of VS. Multimodal therapy is required to manage patients with refractory VS.

• #80 A Review of Drug Therapy in Vestibular Schwannoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7802892/

  Strategies for managing patients with sporadic VS are observation, surgery, and radiotherapy. […] Surgical treatment can cause significant trauma to patients, thus it is only preferable in patients with symptoms of brainstem compression or with small but fast-growth tumors. […] Radiotherapy is suitable for small growing tumors and small tumors with an irregular outline. […] The growing understanding of the mechanisms by which merlin dysregulation induces disease, as well as of signal pathways related to VS growth, has raised hopes for the application of targeted therapies. […] Recent studies have suggested that merlin can regulate multiple pathways implicated in tumorigenesis including retrovirus-associated DNA sequences (Ras)/rapidly accelerated fibrosarcoma (Raf)/mitogen extracellular signal-regulated kinase (MEK)/extracellular-signal-regulated kinases (ERK), mammalian target of rapamycin complex 1 (mTORC1), Rac/p21-activated kinase (PAK)/C-Jun kinase, phosphoinositide 3-kinase (PI3K)/Akt and the intranuclear E3 ubiquitin ligase CRL4 (DCAF1).

• #81 A Critical Overview of Targeted Therapies for Vestibular Schwannoma

  https://www.mdpi.com/1422-0067/23/10/5462

  Bevacizumab has recently been considered as the first-line medical therapy for rapidly growing vestibular schwannomas. Furthermore, new therapeutic strategies targeting the SH3PXD2A-HTRA1 fusion gene, several protein kinases, and the tumor microenvironment may be supportive for the mainstays of management. An immunotherapeutic approach may also be needed to control multiple tumor progression in the long term. In addition to the standard treatment strategy, including surgery and radiotherapy, these targeted medical therapies are needed for multiple and large tumors of VS. Multimodal therapy is required to manage patients with refractory VS.

• #82 New experimental treatment can stop the growth of schwannoma tumours – University of Plymouth

  https://www.plymouth.ac.uk/news/new-experimental-treatment-can-stop-the-growth-of-schwannoma-tumours

  Nasze obecne badanie daje wczesny sygnał, że możemy potencjalnie zapewnić pacjentom ze schwannoma skuteczną alternatywną metodę leczenia ich stanu. […] Dla tych pacjentów perspektywa jednego leku, który mógłby leczyć oba typy guzów bez potrzeby inwazyjnej i ryzykownej chirurgii, jest wyraźnie ekscytującą perspektywą.

Zobacz więcej